Drug makers reaffirm to promote compliance program

Domestic pharmaceutical companies will not provide hospital rebates and contributions for any scientific congresses to be held at home and abroad, as part of its effort to promote a compliance program (CP) for fair trade, according to the Korea Pharmaceutical Manufacturers Association.

The KPMA said on May 23 that efforts for self-purification are needed to root out illicit practices, citing...